Attenuation of MPTP‐induced neurotoxicity and locomotor dysfunction in Nucling‐deficient mice via suppression of the apoptosome pathway

1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced neurotoxicity is one of the experimental models most commonly used to study the pathogenesis of Parkinson's disease (PD). Although the biochemical mechanisms underlying the cell death induced by MPTP remain to be clarified, it has been found that the mitochondrial apoptotic signaling pathway plays an important role in the neurotoxicity of MPTP. Nucling is a novel type of apoptosis‐associated molecule, essential for cytochrome c, apoptosis protease activating factor 1 (Apaf‐1), pro‐caspase‐9 apoptosome induction and caspase‐9 activation following pro‐apoptotic stress. Here we found that Nucling‐deficient mice treated with MPTP did not exhibit locomotor dysfunction in an open‐field test. The substantia nigra dopaminergic neurons of Nucling‐deficient mice were resistant to the damaging effects of the neurotoxin MPTP. Up‐regulated expression of apoptosome was attenuated in Nucling‐deficient mice treated with MPTP. These results indicate an important role for Nucling in MPTP‐induced neuronal degeneration and suggest that the suppression of Nucling would be of therapeutic benefit for the treatment of neurodegeneration in PD.

[1]  T. Sakai,et al.  Identification of a novel, embryonal carcinoma cell-associated molecule, nucling, that is up-regulated during cardiac muscle differentiation. , 2003, Journal of biochemistry.

[2]  J. Langston,et al.  The etiology of Parkinson's disease with emphasis on the MPTP story , 1996, Neurology.

[3]  N. Hattori,et al.  Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. , 1995, Biochimica et biophysica acta.

[4]  K. Tamayose,et al.  An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Perl,et al.  A fluorescent double‐labeling method to detect and confirm apoptotic nuclei in parkinson's disease , 1998, Annals of neurology.

[6]  S. Markey,et al.  MPTP toxicity: implications for research in Parkinson's disease. , 1988, Annual review of neuroscience.

[7]  José Luis de la Pompa,et al.  Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.

[8]  J. Penney,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride Neurotoxicity Is Attenuated in Mice Overexpressing Bcl-2 , 1998, The Journal of Neuroscience.

[9]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[10]  T. Sakai,et al.  Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling. , 2004, The Biochemical journal.

[11]  Junying Yuan,et al.  Apoptosis in the nervous system , 2000, Nature.

[12]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[13]  S. Srinivasula,et al.  Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. , 1998, Molecular cell.

[14]  M. Abercrombie.  Estimation of nuclear population from microtome sections , 1946, The Anatomical record.

[15]  S. Przedborski,et al.  Mechanisms of MPTP toxicity. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[16]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[17]  Francesco Cecconi,et al.  Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development , 1998, Cell.

[18]  D. German,et al.  The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[19]  D. German,et al.  Midbrain dopaminergic neurons in the mouse: Computer‐assisted mapping , 1996, The Journal of comparative neurology.

[20]  T. Mak,et al.  Nucling Recruits Apaf-1/Pro-caspase-9 Complex for the Induction of Stress-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[21]  S. Markey,et al.  MPTP Toxicity: Implications for Research in Parkinson's Disease , 1988 .

[22]  Joseph P Huston,et al.  Behavioral phenotyping of the MPTP mouse model of Parkinson's disease , 2001, Behavioural Brain Research.

[23]  S. Ledoux,et al.  The Role of Apoptosis in Neurodegenerative Diseases , 1998, Metabolic Brain Disease.

[24]  T. Mak,et al.  Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development , 1998, Cell.

[25]  Y. Mizuno,et al.  Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in isolated mitochondria from mouse brains , 1987, Neuroscience Letters.

[26]  R. Elble.  Animal Models of Action Tremor , 2008, Movement disorders : official journal of the Movement Disorder Society.

[27]  Y. Mizuno,et al.  Histochemical detection of apoptosis in Parkinson's disease , 1996, Journal of the Neurological Sciences.

[28]  M. Beal,et al.  Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease , 2001, The Journal of Neuroscience.

[29]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[30]  J. Dichgans,et al.  Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation , 2003 .

[31]  T. Joh,et al.  A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo , 2004, Neurobiology of Disease.

[32]  R. Duvoisin,et al.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. , 1984, Science.

[33]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[34]  D. Jacobowitz,et al.  Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey. , 1984, Psychopharmacology bulletin.

[35]  J. Parks,et al.  The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. , 1999, Biochimica et biophysica acta.